A5030676650- Thyroid Disorders and Treatments
- Neuroendocrine Tumor Research Advances
- Lung Cancer Research Studies
- Neuroblastoma Research and Treatments
- Thyroid Cancer Diagnosis and Treatment
- Cancer Risks and Factors
- Gestational Trophoblastic Disease Studies
- Angiogenesis and VEGF in Cancer
- Growth Hormone and Insulin-like Growth Factors
- Biomarkers in Disease Mechanisms
- Cancer Immunotherapy and Biomarkers
- Venous Thromboembolism Diagnosis and Management
- Multiple and Secondary Primary Cancers
- Pancreatic and Hepatic Oncology Research
- Antenna Design and Analysis
- Full-Duplex Wireless Communications
- Cancer, Lipids, and Metabolism
- Vitamin D Research Studies
- Polyomavirus and related diseases
- Estrogen and related hormone effects
Charles University
2006-2022
General University Hospital in Prague
2011-2018
Masaryk University
2011
scintigraphy with 111 In-pentetreotide, published by the Society of Nuclear Medicine [1] .99m Tc-Depreotide (Neotect ) is another commercially available somatostatin analog that has been approved specifically for detection lung cancer in patients pulmonary nodules [2] .Because relatively high abdominal background and impossibility performing delayed imaging due to short half-life tracer, it less suited neuroendocrine tumors [3] .Somatostatin a regulatory peptide widely distributed human...
aDepartment of Internal Medicine, Endocrine Unit, Uppsala University Hospital, Uppsala, Sweden; bDepartments Medicine and Endocrinological Metabolic Sciences, Genoa, Italy; cG. Genimatas Athens, Greece; dDepartment Surgery, Rigshospitalet, Copenhagen, Denmark; eNetherlands Cancer Centre, Amsterdam, The Netherlands; fDepartment Hepatology Gastroenterology, Campus Virchow-Klinikum, Charite-Universitatsmedizin Berlin, Germany
4095 Background: Global European high quality epidemiologic data on Neuroendocrine Neoplasms (NEN) are lacking. There is limited knowledge the contribution of prognostic factors patient (pt) management. Methods: The multinational ENETS registry (www.enets.org/the_registry.html) was launched in 2015. To date, from 7 countries (Belgium, Czech republic, Germany, Greece, Poland, Spain, Switzerland) were analyzed, including age, gender, primary site, functional syndrome, WHO grade, stage...
265 Background: Breast cancer (BC) is the most common in women. 12% of BC occur women age 20–34. classified as “pregnancy associated” if it diagnosed during pregnancy or within one year after delivery (PABC). We propose two distinct subtypes PABC: and post-partum. This distinction important because epidemiologic data highlights worsened outcomes specific to post-partum cases. The safety treatment an issue for many young Current research does not indicate that negatively affects survival....
22075 Background: Endothelial activation and/or dysfunction with increased expression of adhesion molecules (E-selectin, P-selectin, ICAM-1) and production prothrombotic (t-PA, Fbg, D-dimers) antifibrinolytic (e.g. PAI-1) factors has been demonstrated in patients advanced cancer may be the prerequisite for formation metastases neoangiogenesis. Currently it is unclear if signs endothelial (and dysfunction) are present already non-metastatic breast cancer. Methods: We examined soluble...
The aim of the study was to compare prevalence autoimmune thyroid diseases in three groups women (66 with breast cancer (CaB), 68 colorectal (CaC) and 49 without oncological as a control group). Serum levels thyroid-stimulating hormone (TSH), free thyroxin (fT4), antibodies thyroglobulin (TGB-ab) thyroperoxidase (TPO-ab) tumor markers CEA, CA 15-3 19-9 were investigated all subjects by using chemiluminiscence method. In contrast Graves' disease (no observed case), thyroiditis diagnosed 24.2...